Standard
FDA Clears New Biometric Tool to Help Clinicians Identify Autism in Children
Federal regulators have granted clearance to a new diagnostic assistance tool designed to help clinicians more accurately identify autism in children, marking another step forward in the integration of artificial intelligence and biometrics into pediatric healthcare. The Food and Drug Administration cleared the tool, known as Neurora, this month to inform clinical decisions regarding the…
